An Early Treatment With BKI-1748 Exhibits Full Protection Against Abortion and Congenital Infection in Sheep Experimentally Infected With Toxoplasma gondii

Congenital toxoplasmosis in humans and in other mammalian species, such as small ruminants, is a well-known cause of abortion and fetal malformations. The calcium-dependent protein kinase 1 (CDPK1) inhibitor BKI-1748 has shown a promising safety profile for its use in humans and a good efficacy against Toxoplasma gondii infection in vitro and in mouse models. Ten doses of BKI-1748 given every other day orally in sheep at 15 mg/kg did not show systemic or pregnancy-related toxicity. In sheep experimentally infected at 90 days of pregnancy with 1000 TgShSp1 oocysts, the BKI-1748 treatment administered from 48 hours after infection led to complete protection against abortion and congenital infection. In addition, compared to infected/untreated sheep, treated sheep showed a drastically lower rectal temperature increase and none showed IgG seroconversion throughout the study. In conclusion, BKI-1748 treatment in pregnant sheep starting at 48 hours after infection was fully effective against congenital toxoplasmosis.

Bibliographic Details

Main Authors:	Sánchez Sánchez, Roberto, Imhof, Dennis, Hecker, Yanina, Ferre, Ignacio, Re, Michela, Moreno Gonzalo, Javier, Blanco Murcia, Javier, Mejías López, Elena, Hulverson, Matthew, Choi, Ryan, Ojo, Kayode, Barrett, Lynn, Hemphill, Andrew, Van Voorhis, Wesley, Ortega Mora, Luis Miguel
Format:	info:ar-repo/semantics/artículo biblioteca
Language:	eng
Published:	Oxford University Press 2024-05-17T10:12:54Z
Subjects:	Oveja, Aborto, Infección Experimental, Sanidad Animal, Ewes, Abortion, Toxoplasma Gondii, Exprimental Infection, Animal Health,
Online Access:	http://hdl.handle.net/20.500.12123/17776 https://academic.oup.com/jid/article-abstract/229/2/558/7331060 https://doi.org/10.1093/infdis/jiad470
Tags:	Add Tag No Tags, Be the first to tag this record!